# Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis

> **NCT05737589** · — · UNKNOWN · sponsor: **Xiaorong Dong** · enrollment: 50 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Brain Metastases

## Interventions

- **RADIATION:** Whole-brain radiotherapy

## Key facts

- **NCT ID:** NCT05737589
- **Lead sponsor:** Xiaorong Dong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-13
- **Primary completion:** 2024-02-13
- **Final completion:** 2024-10-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05737589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05737589, "Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05737589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*